FDA Approved: MYCOPHENOLATE MOFETIL — Original Application (Sandoz Inc)

View source ↗

Summary

FDA approved Sandoz Inc's original application for a generic version of mycophenolate mofetil. The product is indicated for prophylaxis of organ transplant reje…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Transplant Rejection Prophylaxis
• Kidney Transplant Rejection Prophylaxis
• Liver Transplant Rejection Prophylaxis

Drugs mentioned

• MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)

Snippet

ORIG AP for MYCOPHENOLATE MOFETIL (MYCOPHENOLATE MOFETIL)